📘 ❞ Epsiprantel ❝ كتاب
كتب طب بيطرى - 📖 كتاب ❞ Epsiprantel ❝ 📖
█ _ 0 حصريا كتاب ❞ Epsiprantel ❝ 2025 Epsiprantel: من كتب طب بيطرى Evidence ratings Evidence Quality Type A Good evidence to support a recommendation for use B Moderate 1 Species specific from at least one large randomized and controlled trial (RCT) or multiple small RCTs C Insufficient D Moderate against E Good 2 Species RCT, disease models, large case studies, pharmacokinetic studies using surrogate endpoints, well designed trials in different species that is considered appropriate comparison 3 Dramatic results either designed, species without controls, controlled without randomization, case 4 Pharmacokinetic endpoints designed pharmacodynamic healthy animals 5 In vitro 6 Opinions of respected authorities on the basis clinical experience reports expert committees © 2008 The United States Pharmacopeial Convention All rights reserved EPSIPRANTEL Veterinary—Oral Local A commonly used brand name veterinary labeled product Cestex Note: For listing dosage forms names by country availability, see Dosage Forms section(s) Category: Anthelmintic Indications text between EL US and EL describes uses are not included U S product labeling Text between EL CAN are included Canadian The EL US or EL CAN designation may signify lack of availability country indicated See Forms section this monograph to confirm Cats dogs Accepted Cestode, gastrointestinal, infection (treatment)— Epsiprantel tablets treatment tapeworms, Dipylidium caninum cats dogs, Taenia taeniaeformis cats, pisiformis in {R 1} Potentially effective (treatment)— Cats dogs: EL US,CAN There suggest epsiprantel Echinococcus granulosus multilocularis; however, there insufficient data recommend can be relied upon clear all treated (Evidence rating: A 1) 9 11} EL Chemistry Chemical group: Pyrazino benzazepine 5} Chemical name: ( ± ) 2 (Cyclohexylcarbonyl) 2,3,6,7,8,12b hexahydropyrazino[2, 1 a ][2]benzazepin 4(1 H ) 4} Molecular formula: C 20 H 26 N 2 0 2 weight: 326 43 1; 4} Description: A stable, white solid 1} Solubility: Sparingly soluble water 1} Pharmacology Pharmacokinetics Mechanism action Effect: The mechanism action epsiprantel appears similar praziquantel, drug disrupts regulation calcium other cations Tetanic muscle contraction paralysis occurs parasite, the tegument becomes vacuolized 8; 10} Absorption: Minimal absorption dogs after oral administration 5} Biotransformation: There no metabolized 8} Concentrations: Peak plasma concentration— Cats: In 83% study, concentration was below level detection samples taken an dose 5 mg per kg body weight (mg kg) 8} When could measured, peak concentration 21 mcg mL 30 minutes dose 8} Dogs: 0 13 (range, <0 5–0 36) hour after 8} Elimination: Cats dogs— Because only trace amounts absorbed, predominantly eliminated feces 8} Less than 1% eliminated urine {R 8} Precautions Consider Reproduction Pregnancy There information safety administering breeding مجاناً PDF اونلاين الطب البيطري (بالإنجليزية: Veterinary medicine) أو البيطرة هو تطبيق المبادئ الطبية والتشخيصية والعلاجية الحيوانات الإنتاجية والمنزلية والبرية يحتوي هذا القسم علي العديد الكتب المتميزة حول المجال يمارس عادة عيادة بيطرية مستشفى بيطري المزرعة للطب دور كبير حماية البشر الأمراض التي تنتقل عن طريق الأكل أصبح التخصص شائعاً السنوات الأخيرة ومن تلك التخصصات: التخدير علم السلوك الجلدية الحالات الطارئة والعناية الحثيثة الباطني امراض القلب السرطان العيون الأعصاب المشتركة المعدية التناسليات والولادة التصوير الشعاعي والجراحة
كتاب
Epsiprantel
كتاب
Epsiprantel
Epsiprantel من كتب طب بيطرى
Evidence ratings
Evidence Quality
Evidence Type
A
Good evidence to support a recommendation for use
B
Moderate evidence to support a recommendation for use
1
Species-specific evidence from at least one large randomized and
controlled trial (RCT) or multiple small RCTs
C
Insufficient evidence to support a recommendation for use
D
Moderate evidence to support a recommendation against use
E
Good evidence to support a recommendation against use
2
Species-specific evidence from a small RCT, disease models,
large case studies, pharmacokinetic studies using surrogate
endpoints, or evidence from well-designed trials in a different
species that is considered appropriate for comparison
3
Dramatic results from either well-designed, species-specific trials
without controls, controlled trials without randomization, or small
case studies
4
Pharmacokinetic studies without surrogate endpoints or well
designed pharmacodynamic studies in healthy animals
5
In vitro
studies
6
Opinions of respected authorities on the basis of clinical
experience or reports of expert committees
© 2008 The United States Pharmacopeial Convention
All rights reserved
EPSIPRANTEL Veterinary—Oral-Local
A commonly used brand name for a veterinary-labeled
product is
Cestex
.
Note: For a listing of dosage forms and brand names by
country availability, see the
Dosage Forms
section(s).
Category:
Anthelmintic.
Indications
Note: The text between
EL
US
and
EL
describes uses that
are not included in U.S. product labeling. Text
between
EL
CAN
and
EL
describes uses that are not
included in Canadian product labeling.
The
EL
US
or
EL
CAN
designation may signify a lack
of product availability in the country indicated.
See the
Dosage Forms
section of this monograph
to confirm availability.
Cats
and
dogs
Accepted
Cestode, gastrointestinal, infection (treatment)—
Epsiprantel tablets are indicated in the treatment of
tapeworms,
Dipylidium caninum
in cats and dogs,
Taenia taeniaeformis
in cats, and
Taenia pisiformis
in dogs.
﴿R-1﴾
Potentially effective
Cestode, gastrointestinal, infection (treatment)—
Cats
and
dogs:
EL
US,CAN
There is evidence to suggest that
epsiprantel is effective in the treatment of
Echinococcus granulosus
and
Echinococcus
multilocularis;
however, there are insufficient data
to recommend a dosage that can be relied upon to
clear the infection in all animals treated (Evidence
rating: A-1).
﴿R-9-11﴾
EL
Chemistry
Chemical group:
Pyrazino benzazepine.
﴿R-5﴾
Chemical name:
(
±
)-2-(Cyclohexylcarbonyl)-
2,3,6,7,8,12b-hexahydropyrazino[2, 1-
a
][2]benzazepin-4(1
H
)-one.
﴿R-4﴾
Molecular formula:
C
20
H
26
N
2
0
2
.
﴿R-4﴾
Molecular weight:
326.43.
﴿R-1; 4﴾
Description:
A stable, white solid.
﴿R-1﴾
Solubility:
Sparingly soluble in water.
﴿R-1﴾
Pharmacology/Pharmacokinetics
Mechanism of action/Effect:
The mechanism of
action of epsiprantel appears to be similar to that of
praziquantel, a drug that disrupts the regulation of
calcium and other cations. Tetanic muscle
contraction and paralysis occurs in the parasite, and
the tegument becomes vacuolized.
﴿R-8; 10﴾
Absorption:
Minimal absorption occurs in cats and
dogs after oral administration.
﴿R-1; 5﴾
Biotransformation:
There is no evidence that
epsiprantel is metabolized.
﴿R-8﴾
Concentrations:
Peak plasma concentration—
Cats:
In 83% of cats in one study, the plasma
concentration of epsiprantel was below the level
of detection in all samples taken after an oral
dose of 5.5 mg per kg of body weight (mg/kg).
{R-
8}
When plasma epsiprantel could be measured,
the peak concentration was 0.21 mcg/mL at 30
minutes after administration of the dose.
﴿R-8﴾
Dogs:
0.13 mcg/mL (range,
#120K
1 مشاهدة هذا اليوم#104K
1 مشاهدة هذا الشهر#16K
14K إجمالي المشاهدات
- 🎁 كن أول كاتب اقتباس في هذه الصفحة واحصل على هديّة 15 من النقاط فوراً 🎁
